Hospital Medicine

Researchers report antibody responses in kidney transplant recipients and the impact of specific regiments utilized by select patients.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

Researchers note the severity of the disease significantly impacts patients’ sleep habits, medication intake, and general mental and physical health.

The priorities established by a panel of experts are designed to improve efficacy and equity in kidney research and care.

Genotype F was the common genotype found at 5.73 per 1000 person-years of follow-up.

The treatment was associated with an increased risk of C difficile colitis.

A recent study has found statins are underutilized for NASH and NAFLD patients.

A leading author of a recent Oxford study speaks of azithromycin, its limitations in treating patients with COVID-19, and the importance of properly utilizing the antibiotic.

More randomized controlled trials are needed to assess their long-term effectiveness, safety, and effects on health-related quality of life.

In a single-center study, no patients were screened annually for HIV and HCV.

Researchers aimed to establish new treatments for patients with COVID-19, but found no evidence of antiviral benefits or decreases in hospitalization and ventilation rates.

Despite its accessibility and affordability, azithromycin does not positively affect patients with COVID-19, according to a new UK study.

Data show 3 life-threatening adverse events required intervention, but were unrelated to buprenorphine induction.

Upadacitinib has shown promising results for a variety of diseases such as severe atopic dermatitis and psoriatic arthritis, but its future remains uncertain.

The treatment met all 5 primary efficacy endpoints as part of the ASCEND program.

This patient group was at an increased risk for future exposure to systemic corticosteroids and anti-TNF biologics.

The FDA Cardiovascular and Renal Drugs Advisory Committee cited concerns over an increase in thrombotic events.

Patients with glucocorticoid-refractory or -dependent chronic GVHD are more likely to experience complete or partial response with the JAK inhibitor than with control therapies.

Metabolomic and preclinical studies have indicated that branched-chain amino acids may protect against neurodegenerative diseases.

Patients with IBD have an increased risk of developing a C difficile infection in comparison to the general population.

While the nerve disease is not life threatening, patients may experience considerable poor quality of life and emotional distress.

About 25% of IBD patients with CDI had a history of antibiotic use.

A new report sheds light on the gaps in knowledge and research surrounding the reproductive health of girls and women with sickle cell disease.

Retinal laser photocoagulation may be performed by a specialist from a distance using telemedicine platforms.

One theory as to why IBD patients are more susceptible to CDI is the use of immunosuppressant treatments.